Video with English and Chinese subtitles: The Truth About the SpaceX IPO JPMorgan Won’t Tell You

Video with English and Chinese subtitles: The Truth About the SpaceX IPO JPMorgan Won’t Tell You | Latest Elon Musk Interview | Jamie Dimon…SpaceX 影片有中英文字幕:你現在頭腦還清醒嗎?可能是世紀騙局向少投資者下手!2021 年在美國已經發生過,你有學精了嗎?首次公開募股(IPO)的真相:摩根大通不會告訴你的事 | 伊隆·馬斯克最新專訪 | 傑米·戴蒙
https://rumble.com/v7axr50-the-truth-about-the-spacex-ipo-jpmorgan-wont-tell-you.html
https://www.tiktok.com/t/ZP8skxvMx/

American logistic expert report from China video: Screwed again: small investors to bail out billionaires from SpaceX, OpenAI, and Anthropic

American logistic expert report from China video: Screwed again: small investors to bail out billionaires from SpaceX, OpenAI, and Anthropic 再度被坑:散戶將為SpaceX、OpenAI和Anthropic的億萬富豪們接盤

https://youtu.be/8FjrSNSGO1A?si=UFH9m94qw2Zpnuv4

SpaceX即將上市,此次發行將使公司估值超過一兆美元。

Anthropic和OpenAI則是人工智慧公司,也計劃在今年稍後進行超大規模的首次公開募股(IPO)。

近期指數規則的變更,將強制退休基金、養老金計劃,以及被動型ETF和共同基金大規模買入這些公司的股票。

過去,新公司必須等到內部人士在禁售期後賣出大部分持股,才能被納入投資指數。同時,公司還需展現穩健的成長紀錄和良好的財務運作實務。

SpaceX will soon go public, in an offering that will value the company at over a trillion dollars.

Anthropic and OpenAI are Artificial Intelligence companies, who also plan megacap IPO’s for later in the year.

Recent changes to indexing rules will compel massive share buys into these companies by retirement and pension plans, and by passive ETF’s and mutual funds.

In the past, new companies were required to wait until insiders sold most of the shares after the lockup periods before being added to investment indices. Companies also needed to show a strong history of growth and sound financial practices.

China’s latest threat: lifesaving medications

China’s latest threat: lifesaving medications. 中國最新的威脅:救命藥物.

中國科學家研發出一種新藥,被譽為對抗肺癌的重大突破,本週消息曝光。

「我認為這裡的結果相當驚人。」美國臨床腫瘤學會(ASCO)的 Monty Pal 博士在 YouTube 評論影片中表示:「我們看到的是整體存活中位數的改善。」

然而,這種英文名為 ivonescimab 的新藥研發,卻被美國政界與媒體描繪成令人擔憂的消息。為什麼?

美國精英與生俱來的自大狂,讓他們必須在每個領域都爭第一。這種心態引發了極度的偏執——意味著中國能救命的新進展,對他們來說反而是壞消息。

國家安全威脅

「現在就是與中國的戰爭。」美國衛生與公共服務部的 Chris Klomp 最近在保守政治行動會議上表示:「我們正面臨國家安全威脅……不是導彈與坦克,而是實驗室與救命藥物。」

喔,不!竟然是救命藥物!

那些卑鄙的中國人還有什麼事做不出來?

但更糟的還在後頭。前美國食品藥物管理局局長 Peter Marks 博士告訴《紐約時報》,如果美國病人對中國藥品產生依賴,可能會「創造出新的荷姆茲海峽」危機。

這句話耐人尋味。不僅偏執心態表露無遺,而且看看他舉的例子。美國在伊朗製造了一個完全沒必要的問題,導致數千人死亡、數百萬人面臨燃料短缺。

西方的政治操作對雙方——以及無辜的第三方——都會帶來真實世界的後果。

中國科學家拿下頂尖席位

上週,在 ASCO 年度全球腫瘤學家大會上,這個醫療議題進一步升溫。

五大突破性研究成果獲得最高級別發表席位——當其中一個席位由在中國進行試驗的中國醫學科學家拿下時,政客與記者們大吃一驚。

問題所在

讓我們逐一檢視各項問題:

是否有人嚴重質疑這款新藥 ivonescimab 無效,或只對中國人有效?
— 沒有。該藥由中國公司康方生物(Akeso Biopharma)研發,已在中國成功使用。此後也在美國、加拿大和歐洲進行了全球研究,以確保數據多元化。

是否擔心中國可能拒絕向美國人提供這種藥或其他藥品?
— 沒有。中國公司保留自家國家的權利,然後將藥品授權給美國公司在美國銷售。Ivonescimab 在美國是由邁阿密的 Summit Therapeutics 公司生產。

是否擔心數據造假?
— 沒有。醫學學術期刊《柳葉刀》已刊登研究指出,使用新藥的患者死亡率降低了 34%。

問題在於中國抄襲了美國的藥嗎?
— 不是。科學不是這樣運作的。科學進步來自於數據驅動的突破,無論突破發生在何處。

那問題到底是什麼?

老問題:美國需要主宰一切,不管誰會受傷。就中國藥物而言,如果藥品被延遲或禁止,這種無謂敵意的受害者將包括美國公民。

築起高牆
川普總統已簽署法案,禁止美國政府機構與中國生技公司簽訂合約,無論其產品與服務多麼有益。

此外,國會中的政客正試圖通過規則,阻止承認來自中國大陸或香港臨床試驗的數據。

有些美國記者似乎也對誰在創造突破背後的政治,比對科學突破本身更感興趣。《紐約時報》上週關於此話題的報導開頭是這樣寫的:

「數十年來,腫瘤學家的年度會議上,主要展示的是在美國和歐洲醫院進行的藥物試驗。

但在本週末於芝加哥舉行的今年會議上,處處都可見到中國崛起為藥物研發強權的跡象——以及許多人認為這對美國生技產業構成的威脅。」

中國最新的威脅:救命藥物。

CHINESE SCIENTISTS created a new medicine that is being hailed as a breakthrough in the fight against lung cancer, it was revealed this week.

“And the results here, I think, are quite astounding,” said Dr Monty Pal of the American Society of Clinical Oncology (ASCO) in a YouTube video review. “What we see here is an improvement in median overall survival.”

Yet the development of the new drug, called ivonescimab in English, is being portrayed as worrying news by politicians and media in the US. Why?

The US elite’s congenital megalomania means it has to be number one in every field. This need triggers extreme paranoia—and means that Chinese lifesaving advances are bad news.

.

NATIONAL SECURITY THREAT

“It’s a war right now with China,” said United States Department of Health and Human Services Chris Klomp at the recent Conservative Political Action Conference.

“We face a national security threat right now…it’s not one of missiles and tanks. It’s of laboratories and life-saving medications.”

Oh no! Not life-saving medications!

Will the dastardly Chinese stop at nothing?

But it gets worse. If American patients become reliant on the Chinese for drugs, there is a risk of “creating a new Strait of Hormuz”, said former FDA chief Dr. Peter Marks, quoted in the New York Times.

That’s a telling remark. Not only is the paranoia up front and center, but look at the example he chose. The US created an entirely needless problem in Iran, with thousands dead and millions suffering from fuel shortages.

Western political plays have real world consequences for both sides–and innocent parties, too.

CHINA SCIENTISTS GET TOP SPOT

The medical issue escalated last week at the annual ASCO global gathering of oncologists (cancer doctors).

The five biggest breakthroughs are given top-of-the-bill presentation slots—and politicians and journalists were shocked when one of them went to Chinese medical scientists who conducted their trials in China.

THE ISSUES

Let’s look at the issues, one by one:

Are there serious concerns that the new drug, ivonescimab, doesn’t work or only works on Chinese people?

  • No. The drug was created by a Chinese firm called Akeso Biopharma, and it is already used successfully in China. There has since been a global study in the United States, Canada and Europe, too, to ensure diversified data.

Are there worries that China may deny sending this and other drugs to Americans?

  • No. Chinese companies keep the rights for their own country and then license the drugs in the US to American firms. Ivonescimab in the US is a product of Summit Therapeutics of Miami.

Is there concern that the data is false?

  • No. The Lancet, a medical academic journal, has already printed a study saying that people who got the new drug had a 34 percent lower death rate.

Is the problem that the Chinese copied the drug from the US?

  • No. That’s not how science works. Science advances through data-driven breakthroughs, irrespective of where they take place.

So what is the problem?

It’s the usual one: the US needs to dominate everything, whoever gets hurt. In the case of medicines from China, the victims of needless hostility will include US citizens, if drugs are delayed or banned.

BUILDING WALLS
President Donald Trump has already signed legislation that prevents US government bodies signing contracts with Chinese biotech firms, however beneficial their products and services may be.

And separately, politicians in Congress are trying to get rules passed that prevent the recognition of data from clinical trials in Mainland China or Hong Kong.

Some US journalists also appear less interested in the scientific breakthroughs than the politics of who is making them. The New York Times report last week on the topic began with these lines:

“For decades, an annual gathering of oncologists has featured drug trials that were run mainly at American and European hospitals.

“But at this year’s meeting, which is being held in Chicago this weekend, the signs are everywhere of China’s ascendance as a powerhouse in drug development — and of the threat that many believe it poses to American biotechnology.”

China’s latest threat: lifesaving medications.

Ronny Tong Ka Wah; the Roads – Some time ago…

Ronny Tong Ka Wah; the Roads – Some time ago, my wife and I visited Yunnan and found that the highways here are world-class in terms of design, construction and maintenance. 湯家驊: 路 – 前陣子和太太到雲南旅遊,發覺無論在設計、建造和保養方面,這裏的高速公路均達世界水平。

有一天發覺路上車並不多,便問導遊為什麼這條路特別少車輛?導遊說:「噢,這條路建成不足一年。」有點好奇,便再追問這條路能連結到哪個城市?他笑笑說,沒有什麼城市,只是接連到一些偏遠村落;他進一步解說,山區的農民之前每周要背着自家種植的蔬果步行一整天到市集擺賣,今天高速公路到了他們的門外,每周會有小伙子駕着輕型貨車來向他們收購農作物;收入多了,生活穩定了,村落也富裕起來。我們聽了很感動,原來國家不少基建項目不是為了追求多少經濟回報,而只是希望令人民生活得以改善;這便是今天的中國。

從另一個角度看,公開數據顯示國家在過去10 年增建了30 萬里公路、4 萬里高速;相比美國同期只建設了24 萬里公路,高速更毫無增建。在鐵路方面,國家同期建設了4 萬里鐵路及2 萬里高鐵;美國則不但沒增加鐵路,更有退減趨勢。這10 年,國家動用了4.8% 生產總值或60% 國債於基建,而美國只是用了0.51% 生產總值或4.25% 國債於基建設施。你會說,啊,但美國是已發展國家;問題是已發展國家便不用增建基建?當然不是!事實是,美國與中國在這方面不同的地方,只是管治價值觀而已。

我們在殖民地時代長大的這一輩,年輕時有一種羨英崇美的傾向;但見識多了,人成熟了,我們開始醒覺什麼制度也不及正確的價值觀和如何改善人民生活質素重要。我們有自己要走的路,又何須理會他人如何走他們的路?

Ronny Tong Ka Wah; the Roads – Some time ago, my wife and I visited Yunnan and found that the highways here are world-class in terms of design, construction and maintenance.

One day I realized that there were not many cars on the road, I asked the guide why This road is particularly low on cars? The guide said, “Oh, this road was built less than a year ago. A little curious, then asked what city can this road connect to? He laughed and said that there was no city, just a few remote villages; he further explained that farmers in the mountains used to walk all day to the market every week with their own fruits and vegetables, and today the highway came outside their door, and every week young men would drive light trucks to buy crops from them; more income, life was stable, and the village was rich. We are very moved to hear that many infrastructure projects in the country are not for the pursuit of economic returns, but only for the improvement of people’s lives; this is China today.

From another perspective, public data shows that the country has added 300,000 miles of highway and 40,000 miles of highway over the past 10 years; compared to only 240,000 miles of highway built in the United States during the same period. In terms of railroads, the country built 40 thousand miles of railway and 20,000 miles of high-speed rail in the same period; the United States not only did not add railroads, but also In this decade, the country spent 4.8% of its GDP or 60% of its national debt on infrastructure, while the US spent only 0.51% of its GDP or 4.25% of its national debt on infrastructure. You would say, ah, but America is a developed country; the problem is that developed countries don’t need to build infrastructure? Of course not! The fact is, the difference between the US and China in this respect is just governing values.

Our generation raised in the colonial era has a tendency to be elite in our youth; but with more knowledge and maturity, we begin to realize that no system is less important than the right values and how to improve the quality of life of the people. We have our own way to go, why should we care how others go their way?

I don’t know how real is this job report

I don’t know how real is this job report: “U.S. payrolls rose by 172,000 in May”. I know at least 2 companies in SF fired/layoff over 30 engineers with average annual salary of US$200,000 我不知道這份就業報告有多真實:「美國五月份就業人數增加了17.2萬人」。我知道舊金山至少有兩家公司解僱/裁掉了超過30名工程師,他們的平均年薪為20萬美元.

There is no future for smart Chinese scientists in US:

There is no future for smart Chinese scientists in US: A physicist who was awarded a fellowship reserved for the “brightest young scientists” in the US and Canada for his work hunting for black holes has returned to China. 聰明的中國科學家在美國沒有前途:一位物理學家因其尋找黑洞的工作,獲得了一項專為美國和加拿大「最傑出年輕科學家」保留的研究獎學金,如今已返回中國。

Reminder: Tiananmen Square (1989) was not the only agression on China by the USHow many times does the same pattern have to repeat before people finally see it for what it is?

Reminder: Tiananmen Square (1989) was not the only agression on China by the US
How many times does the same pattern have to repeat before people finally see it for what it is?
This has been a continuous, decades-long hybrid warfare campaign to destabilise and fragment China.
The modern colour revolution playbook — youth movements, foreign-funded NGOs, media hype, symbolic colours, and fake “democracy” demands — was refined in Serbia (Otpor! 2000) and rolled out like clockwork elsewhere.
But against China, it runs much deeper, with direct CIA fingerprints on funding, training, and orchestration aimed at internal chaos.
Multiple fronts, same tired playbook:

  • Tibet: Decades of CIA backing for separatist elements, from old proxy operations to today’s weaponisation of the Dalai Lama as a political tool and endless separatist narratives pushed from abroad. https://x.com/angeloinchina/status/1599732940476669955
  • Xinjiang: Heavy Western funding via NED and aligned groups for “Uyghur organisations” and “East Turkestan” fantasies, pumping colour revolution-style agitation and fake “genocide” claims to manufacture outrage and justify containment. https://x.com/angeloinchina/status/2061302054329766365
  • Hong Kong 2019: Pure textbook colour revolution — foreign training, years of NED/NDI money, organised violence, black blocs, Molotovs, and nonstop Western media cheerleading to tear apart “one country, two systems.” Order was restored. Stability returned. https://x.com/angeloinchina/status/2016744163031863320
    Tiananmen fits perfectly in this long continuum: legitimate local grievances cynically amplified by overseas funding, VOA propaganda, Gene Sharp-inspired tactics, and post-crackdown extractions like Operation Yellowbird. NED and CIA-linked networks were all over it, part of the broader push to derail China’s path. https://x.com/angeloinchina/status/1979086630049976593
    This hybrid assault has been continuous for over 75 years. As the Pentagon Papers laid bare, US planners didn’t just want to contain China — they wanted to “retard the economic progress” of Communist Asian states. China’s success was the real threat. That same mentality runs from 1950s memos straight through to today’s “pacing threat” strategies. https://x.com/angeloinchina/status/2062398538756313578
    From Cold War paramilitary ops to today’s NGO-media-youth hybrid versions, Tibet, Xinjiang, Hong Kong, and Taiwan are all pieces of the same puzzle: manufacture internal chaos to stop a sovereign China from rising.
    Bottom line: For over 75 years, China has faced relentless Western — mostly US-led — attacks meant to contain, weaken, and break it apart. Military encirclement, proxy insurgencies, economic sabotage, information warfare, colour revolutions… the methods change, the objective never does.
    These are not spontaneous freedom movements. They are hybrid warfare.
    Context, funding trails, historical patterns, and real outcomes matter far more than the selective Western script.
    Wake up to the full picture.​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
    apart. Military encirclement, proxy insurgencies, economic sabotage, information warfare, colour revolutions… the methods change, the objective never does. These are not spontaneous freedom movements. They are hybrid warfare. Context, funding trails, historical patterns, and real outcomes matter far more than the selective Western script. Wake up to the full picture.

Video: Why China Greater Bay Area?

Video: Why China Greater Bay Area? 不少金山亞伯包括金山少伯為何在香港,中國找不到女朋友更莫講話找老婆,尤其是那些智商和情商高受過高等教育或家中有一點錢的中國女仔跟本不會看你一眼!香港比美國進步自由,稅又低,為什麼香港人搬去中國大灣區居住,包括成千上萬的美國和加拿大華僑反回中國大灣區居住或退休呢!

https://youtu.be/JC59KVHmuZI?si=Q_6bus_BOwXj0jKL

🏆 搬唔搬?香港 $1.2萬住蝸居 vs 深圳 $7000 租大屋!年青人兩地生活,原來係買緊「情緒價值」? 搬不搬?香港 $1.2萬住蝸居 vs 深圳 $7000 租大屋!年青人兩地生活,原來係買緊「情緒價值」?

近年來,越來越多港人北上開啟雙城生活,每天跨城通勤往返深港。很多人以為深圳租屋純粹是為了省錢,避開香港高昂的生活成本以及納米樓。但當我真正開啟大灣區雙城生活之後發現,除了表面上的「數字帳」,背後其實隱藏著一本決定你生活品質的「情緒帳」! 這支影片不說廢話,我會用客觀真實的數據與生活細節,拋出 3 個靈魂拷問。
從香港租樓市區 $1.2萬的蝸居對比深圳租房 $7000 的大屋苑,到快遞逾期罰款拆解兩地服務邏輯,幫你無情計算「北上長住」的真實 ROI(投資回報率)!你到底是在香港追求生存,還是去深圳買回生活的「情緒價值」?

⏱️ 【時間線 Chapter Timeline – 直接點擊空降】
00:00 晚拿快遞要罰錢?香港 vs 內地生活摩擦力與生活成本對比
00:36 搬還是不搬?港人北上跨城通勤的 3 個靈魂拷問
00:43 居住空間量度:你對納米樓的「空間」有多敏感?
01:04 真實租盤對比:HKD $1.2萬 (香港市區) vs CNY 6800 (深圳北站大屋苑)
02:06 從「生存」到「生活」:有條件養寵物的「情緒價值」
03:35 生活瑣事量度:你願意為「減少生活摩擦」支付多少過路費?
03:57 雙城生活底層邏輯:香港「人找服務」 vs 內地「服務找人」
05:04 職場與事業量度:你需要香港的拼搏跳板,還是深圳的回血基地?
06:25 總結:港人北上長住的真正原因,算清你自己的大灣區生活優先次序

Iran get the parasites out of the Middle East

Iran get the parasites out of the Middle East. Once upon a time, before Febuary 28th 2026, Iran was surrounded by Western military bases. That is no longer, so Iran has proven very good at pest control. 把伊朗這群寄生蟲趕出中東。在2026年2月28日之前的某個時候,伊朗還被西方軍事基地包圍。如今情況不再,這證明伊朗非常擅長害蟲防治.